期刊文献+

原发性醛固酮增多症38例临床分析 被引量:1

下载PDF
导出
出处 《郑州大学学报(医学版)》 CAS 北大核心 2009年第2期453-454,共2页 Journal of Zhengzhou University(Medical Sciences)
  • 相关文献

参考文献5

二级参考文献20

  • 1刘雪娜,周宪梁,刘亚欣,顾晴,陈改玲,孙晓昕,丰雷,惠汝太.原发性醛固酮增多症合并高血浆肾素活性的临床病例分析[J].中国分子心脏病学杂志,2004,4(4):233-234. 被引量:1
  • 2张炜 孙立昊 胡仁明.增生型原醛的诊断[A].见:胡仁明主编.内分泌代谢病临床新技术[M].北京:人民军医出版社,2002.208-216. 被引量:3
  • 3MULATERO P,STOWASSER M, LOH K C.Increased diagnosis of primary aldosteronism,including surgically correctable forms,in centers from five continents[J]. J Clin Endocrinol Metab,2004,89(3):1045-1050. 被引量:1
  • 4YOUNG W F Jr.Minireview:primary aldosteronism-changing concepts in diagnosis and treatment[J]. Endocrinology,2003,144(6):2208-2213. 被引量:1
  • 5STRUTHERS A D. Aldosterone-induced vasculopathy[J]. Molecular and Cellular Endocrinology,2004,217(1-2):239-241. 被引量:1
  • 6ROSSI G P, DI B V, GANZAROLI C, et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism[J]. Hypertension,2002,40(1):23-27. 被引量:1
  • 7MILLIEZ P,GIRERD X,PLOUIN P F.Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J]. J Am Coll Cardiol,2005,45(8):1243-1248. 被引量:1
  • 8STOWASSER M, GORDON R D. Primary aldosteronism-careful investigation is essential and rewarding[J]. Molecular and Cellular Endocrinology,2004,217(1-2):33-39. 被引量:1
  • 9STOWASSER M,GORDON R D,GUNASEKERA T G,et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective' screening of hypertensive patients[J]. J Hypertens,2003,21(11):2149-2157. 被引量:1
  • 10CONN J W, COHEN E L,ROVNER D R,et al. Normokalemic primary aldosteronism. A detectable cause of curable “essential” hypertension[J]. JAMA,1965,19(193):200-206. 被引量:1

共引文献22

同被引文献23

  • 1Hansson GK, Hermansson A. The immune system in alherosclerosis[J]. Nat Immunol, 2011, 12(3): 204-12. 被引量:1
  • 2Tsou CL, Peters W, Si Y, ct al. Critical roles for CCR2 and MCP-3in monocyte mobilization from bone marrow and recruitment toinflammatory sites[J]. J Clin Invest, 2007,117(4): 902-9. 被引量:1
  • 3Jang MK, Kim JY, Jeoung NH, et al. Oxidized low-dcnsitylipoproteins May induce expression of monocyte chemotacticprotein-3 in atherosclerotic plaques [J]. Biochem Biophys ResCommun, 2004, 323(3): 898-905. 被引量:1
  • 4Wang X, Li X, Yuc TL, ct al. Expression of monocyte chemotacticprotein-3 mRNA in rat vascular smooth muscle cells and in carotidartery after balloon angioplasty [J]. Biochim Biophys Acta, 2000,1500(1):41-8. 被引量:1
  • 5Maddaluno M, Di Lauro M, Di Pascale A, et al. Monocytechemotactic protein-3 induces human coronary smooth muscle cellproliferationfj]. Atherosclerosis, 2011, 217(1): 113-9. 被引量:1
  • 6Davis J, Crampton SP. Hughes CCW. Isolation of Human Umbi-lical Vein Endothelial Cells (HUVEC)[J ]. J Vis Exp, 2007(3): 183. 被引量:1
  • 7Grciffenberg L, Sokolovic Z, Schnittler HJ, et al. Listeriamonocytogenes-infcctcd human umbilical vein endothelial cells:intemalin-indepcndcnt invasion, intracellular growth, movement,and host cell responses [J]. FEMS Microbiol Lett, 1997, 157(1):163-70. 被引量:1
  • 8Zelvyte I, Dominaitienc R, Crisby M, et al. Modulation ofinflammatory mediators and PPARgamma and NFkappaBexpression by pravastatin in response to lipoproteins in humanmonocytes in ri/ro[J]. Pharmacol Res, 2002, 45(2): 147-54. 被引量:1
  • 9刘伟,朱自强,祖淑玉,等.脐静脉内皮细胞组织因子及其抑制物越中银杏内酯B的干预效[J].中国织工程研究与临床康复,2007,11(6): 1053-6. 被引量:1
  • 10Yadav A, Saini V,Arora S. MCP-I: chemoattractant with a rolebeyond immunity: a review[J].Clin Chim Acta, 2010, 411(21-22):1570-9. 被引量:1

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部